Original ArticleConsensus Nomenclature for Reporting Neovascular Age-Related Macular Degeneration Data: Consensus on Neovascular Age-Related Macular Degeneration Nomenclature Study Group
Abbreviations and Acronyms
Cited by (0)
Financial Disclosure(s): The author(s) have made the following disclosure(s): R.F.S.: Consultant – Topcon Medical Systems, Roche, Genentech; Royalties – Topcon Medical Systems, DORC.
G.J.J.: Heidelberg Engineering, Novartis, Roche.
D.S.: Consultant – Amgen, Bayer, Genentech, Novartis, Optovue; Financial support – Genentech, Regeneron.
K.B.F.: Consultant – Novartis, Allergan, Zeiss, Optovue, Heidelberg Engineering; Financial support – Genentech/Roche.
S.R.S.: Consultant – Amgen, Allergan, Bayer, Novartis, Genentech/Roche, Oxurion, Heidelberg Engineering, Optos, Carl Zeiss Meditec, Centervue; Financial support – Carl Zeiss Meditec; Nonfinancial support – Nidek, Topcon.
G.S.: Consultant – Heidelberg Engineering, Nidek, Centervue; Financial support – Heidelberg Engineering, Carl Zeiss Meditec, Optovue, Nidek, Centervue, Topcon.
N.K.W.: Consultant – Optovue, Topcon; Nonfinancial support – Optovue, Carl Zeiss Meditec, Nidek.
P.J.R.: Consultant and Financial support – Carl Zeiss Meditec.
F.G.H.: Consulting fees – Heidelberg Engineering, Carl Zeiss Meditec, Bayer, Novartis, Genentech/Roche, Acucela, Apellis, Allergan, Pixium, Kodiak, Lin Bioscience; Financial support – Heidelberg Engineering, Carl Zeiss Meditec, Centervue, Bayer, Novartis, Genentech/Roche, Acucela, Apellis.
E.H.S.: Consultant – Allergan, Bayer, Novartis, Roche.
S.Y.C.: Consultant – Allergan, Bayer, Novartis, Roche, Thea, Tilak.
G.Q.: Consultant – Alimera, Allergan, Bayer, Lumithera, KBH, Novartis, Roche, Sandoz, Sifi, Zeiss, Topcon, Thea, Heidelberg, Fidia-Sooft, Bausch & Lomb.
D.B.: Consultant – Alcon, Genentech, Regeneron, Allergan, Novartis, Oxurion.
A.G.: Consultant – Novartis, Thrombogenics; Nonfinancial support – Bayer.
C.R.B.: Consultant – Genentech, Novartis.
S.S-V.: Financial support – Accucela, Allergan, Bayer, Bioeq/Formycon, Centervue, Genentech/Roche, Katairo, Novartis; Consultant – Allergan, Bayer, Bioeq/Formycon, Carl Zeiss MediTec AG, Galimedix, Genentech/Roche, Novartis, Heidelberg Engineering.
U.S-E.: Consultant – Boehringer Ingelheim, Genentech, Novartis, Roche.
R.G.: Consultant – Novartis, Bayer, Apellis, Roche/Genentech.
K.C.: Consultant – Ophthotech, Allergan, Regeneron, Roche, Heidelberg Engineering, Novartis, Genentech; Financial support – Ophthotech.
J.M.M.: Consultant – Novartis, Roche, Cellcure, Kodiak, Notalvision, Reneuron; Financial support – Novartis, Roche, Bayer, Ophthotech, Reneuron, Apellis, Thrombogenics, Kodiak; Equity owner – Ophthotech, Notalvision.
R.T.: Consultant – Allergan, Novartis, Bayer, Genentech, Roche, Oculis, Alcon; Financial support – Novartis, Bayer, Allergan, Alcon; Nonfinancial support – Zeiss, Moria.
J.F.: Consultant – Topcon; Royalties – Optovue.
Supported in part by the Macula Society, Cleveland, OH; Heidelberg Engineering, Inc; Optovue Inc, Topcon Medical Systems, Inc, and Zeiss-Meditec, Inc. The sponsors had no role in the design or conduct of this research and no input in writing the article.
HUMAN SUBJECTS: No human subjects were included in this study.
No animal subjects were included in this study.
Author Contributions:
Conception and design: Spaide, Jaffe, Sarraf, Freund, Sadda, Staurenghi, Waheed, Chakravarthy, Rosenfeld, Holz, Souied, Cohen, Querques, Ohno-Matsui, Boyer, Gaudric, Blodi, Baumal, Li, Coscas, Brucker, Singerman, Luthert, Schmitz-Valckenberg, Schmidt-Erfurth, Grossniklaus, Wilson, Guymer, Yannuzzi, Chew, Csaky, Monés, Pauleikhoff, Tadayoni, Fujimoto
Analysis and interpretation: Spaide, Jaffe, Sarraf, Freund, Sadda, Staurenghi, Waheed, Chakravarthy, Rosenfeld, Holz, Souied, Cohen, Querques, Ohno-Matsui, Boyer, Gaudric, Blodi, Baumal, Li, Coscas, Brucker, Singerman, Luthert, Schmitz-Valckenberg, Schmidt-Erfurth, Grossniklaus, Wilson, Guymer, Yannuzzi, Chew, Csaky, Monés, Pauleikhoff, Tadayoni, Fujimoto
Data collection: Spaide, Jaffe, Sarraf, Freund, Sadda, Staurenghi, Waheed, Chakravarthy, Rosenfeld, Holz, Souied, Cohen, Querques, Ohno-Matsui, Boyer, Gaudric, Blodi, Baumal, Li, Coscas, Brucker, Singerman, Luthert, Schmitz-Valckenberg, Schmidt-Erfurth, Grossniklaus, Wilson, Guymer, Yannuzzi, Chew, Csaky, Monés, Pauleikhoff, Tadayoni, Fujimoto
Obtained funding: Spaide, Jaffe, Sarraf, Freund, Sadda, Staurenghi, Waheed, Chakravarthy, Rosenfeld, Holz, Souied, Cohen, Querques, Ohno-Matsui, Boyer, Gaudric, Blodi, Baumal, Li, Coscas, Brucker, Singerman, Luthert, Schmitz-Valckenberg, Schmidt-Erfurth, Grossniklaus, Wilson, Guymer, Yannuzzi, Chew, Csaky, Monés, Pauleikhoff, Tadayoni, Fujimoto
Overall responsibility: Spaide, Jaffe, Sarraf, Freund, Sadda, Staurenghi, Waheed, Chakravarthy, Rosenfeld, Holz, Souied, Cohen, Querques, Ohno-Matsui, Boyer, Gaudric, Blodi, Baumal, Li, Coscas, Brucker, Singerman, Luthert, Schmitz-Valckenberg, Schmidt-Erfurth, Grossniklaus, Wilson, Guymer, Yannuzzi, Chew, Csaky, Monés, Pauleikhoff, Tadayoni, Fujimoto